PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada (O.T.); Neuroimmunology and Neurovirology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (F.S.); and Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, New York (I.T.) tavassoly@gmail.com otavasso@sfu.ca.\', \'Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada (O.T.); Neuroimmunology and Neurovirology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (F.S.); and Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, New York (I.T.).\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1124/molpharm.120.000098
?:hasPublicationType
?:journal
  • Molecular pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32913137
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.076
?:rankingScore_hIndex
  • 182
is ?:relation_isRelatedTo_publication of
?:title
  • Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32913137>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32913137>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all